Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock protein family E (Hsp10) member 1 pseudogene 24 (HSPE1P24) is a predicted pseudogene located in the human genome[5]. Pseudogenes are typically non-protein-coding DNA sequences similar to known genes but rendered nonfunctional by mutations[6]. While some pseudogenes can regulate their cognate protein-coding genes by serving as RNA decoys for microRNAs or producing regulatory RNAs, there is no direct evidence or characterized biological function or therapeutic implication for HSPE1P24 itself[2][5][6]. There are no known diseases, drugs, or biomarker uses linked to this pseudogene and it is not considered a conventional drug target. Key points: - This entry represents a *pseudogene*, not a functional protein, receptor, or enzyme[5][6]. - There are no reports that it serves as a therapeutic target, disease marker, or drug-interacting molecule, nor that it plays a direct role in cellular processes or pathologies[5]. - Some general biological roles of pseudogenes, such as acting as competing endogenous RNAs, have been described in the literature, but no evidence exists for HSPE1P24 specifically[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein family E (Hsp10) member 1 pseudogene 24 (HSPE1P24).